Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Angiogenesis|December 23, 2019
Vessel co-option and resistance to anti-angiogenic therapyElizabeth A Kuczynski, Andrew R Reynolds
Chinese Journal of Cancer|November 27, 2016
Implications of vessel co-option in sorafenib-resistant hepatocellular carcinomaElizabeth A Kuczynski, Robert S Kerbel
STAR Protocols|March 11, 2023
Longitudinal tracking of T cell lymphomas in mice using flow cytometryElizabeth A Kuczynski, Larissa Carnevalli, Charles Sinclair
Oncology|October 12, 2011
VEGFR2 expression and TGF-β signaling in initial and recurrent high-grade human gliomaElizabeth A Kuczynski, Steven G Patten, Brenda L Coomber
Nature Reviews. Clinical Oncology|September 4, 2013
Drug rechallenge and treatment beyond progression--implications for drug resistanceElizabeth A Kuczynski, Daniel J Sargent, Axel Grothey, et al.
Cancer Research|April 25, 2015
Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular CarcinomaElizabeth A Kuczynski, Christina R Lee, Shan Man, et al.
Nature Reviews. Clinical Oncology|March 1, 2019
Vessel co-option in cancerElizabeth A Kuczynski, Peter B Vermeulen, Francesco Pezzella, et al.
Nature Reviews. Cancer|March 10, 2018
Non-angiogenic tumours and their influence on cancer biologyTom Donnem, Andrew R Reynolds, Elizabeth A Kuczynski, et al.
Molecular Cancer Therapeutics|February 28, 2018
Impact of Chemical-Induced Mutational Load Increase on Immune Checkpoint Therapy in Poorly Responsive Murine TumorsElizabeth A Kuczynski, Janna Krueger, Annabelle Chow, et al.
Pageof 2